Smith Nephew ADR Representing 2 Ord Shs SNN

Healthcare Medical Devices

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

NYSE:SNN - Post by User

Smith Nephew ADR Representing 2 Ord Shs > Div makes this attractive

<< Previous

Bullboard Posts

Next >>

Comment by radcaton Oct 30, 2022 11:15am

47 Views

Post# 35058480

RE:RE:RE:Div makes this attractive

Since you are a Divi hound, check out Energy Transfer (ET). I have followed them since early 2022 when their share price was at $8.00 U.S. with a dividend of $0.62 U.S. The dividend has been raised each quarter since then. This pas week it was increased from $0.92 U.S. to $1.06. Management has stated they want the dividend back to Pre covid-19 level of $1.22. I believe that will happen when they report Q-4 or 2022 results. Closed Friday at $12.53 U.S. Dividend $1.06 Yield 8.53% Hard to believe the share price was $4 bucks with a yield of 20%

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle